StockNYSEKVUE

Kenvue

$17.61

+0.00 (+0.00%)today

Valuation & earnings

P/E ratio: 20.72
Forward P/E: 14.2
EPS (ttm): $0.85
Forward EPS: $1.24
Price/book: 3.2
PEG ratio: 1.4
Dividend yield: 4.77%
Payout ratio: 97.65%

Financials (ttm)

Revenue (ttm): 15.4B
Revenue growth: 3%
Profit margin: 10.76%
Return on equity: 15.58%
Total cash: 1.1B
Total debt: 8.6B

Earnings (EPS)

Quarter	Estimate	Actual	Surprise
Sep 30, 2025	0.26	0.28	+5.72%
Dec 31, 2025	0.22	0.27	+21.24%
Mar 31, 2026	0.26	0.32	+23.03%
Jun 30, 2026	0.32	0.31	-2.82%

Next earnings date: Nov 5, 2026

Analyst view

Consensus ratingHold14 analysts

Strong buy 1Buy 1Hold 12

12-month price targetsImplied upside: +10.73%

19.5

LowCurrent priceHigh

Dividends

Dividend yield: 4.77%
Dividend (annual): $0.84
Ex-dividend date: Sep 21, 2026

Recent payments

Sep 21, 2026 · $0.21Aug 12, 2026 · $0.21May 13, 2026 · $0.21Feb 11, 2026 · $0.21Nov 12, 2025 · $0.21

Key stats

Previous close: $17.61
Day range: 17.61 – 17.88
52-week range: 14.02 – 20.13
Volume: 17.5M
Avg. volume: 22.3M
Market cap: 33.8B
Beta: 0.43
52-week change: 7.25%
Currency: USD

Profile

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and othe(English)

Sector: Consumer Defensive
Industry: Household & Personal Products
Employees: 21,780
Headquarters: Summit, United States

Visit website

Market data provided by Yahoo Finance, may be delayed. For informational purposes only — not investment advice.